• MHY1485 as an mTOR Activator: Optimizing Autophagy and Ovari

  2026-05-20

  MHY1485 offers a unique advantage as a potent mTOR activator, enabling precise control over autophagy inhibition and follicle development models. This article translates cutting-edge research and product-specific guidance into actionable workflows and troubleshooting tips for advanced cell signaling and metabolism studies.

• Agatoxin-IVA-Sensitive Calcium Channels in Cardiac Vagal Neu

  2026-05-19

  This article reviews a pivotal study elucidating the specific roles of agatoxin-IVA-sensitive voltage-dependent calcium channels in mediating both presynaptic and postsynaptic nicotinic activation of cardiac vagal neurons. The findings refine our understanding of calcium channel subtype contributions to cardiac autonomic regulation and offer mechanistic insights valuable for neurophysiology and translational modeling.

• β-Blocker Selectivity Governs Hematopoietic Regeneration Pos

  2026-05-19

  This study establishes that nonselective β-adrenergic blockers, but not β1-selective agents such as Metoprolol Tartrate, impair hematopoietic regeneration following hematopoietic cell transplantation in both mouse models and human patients. The findings underscore the importance of receptor selectivity in post-transplant management and experimental modeling of hematopoietic recovery.

• Troglitazone: PPARγ Agonist for Advanced Cancer and Diabetes

  2026-05-18

  Troglitazone stands out as a dual PPARγ/α agonist, enabling precision modulation of lipid and glucose metabolism as well as anti-tumor pathways in translational research. This article delivers hands-on protocol guidance, troubleshooting insights, and a critical synthesis of recent advances in targeting tumor-associated macrophages, empowering scientists to maximize the impact of Troglitazone in high-impact experimental settings.

• Distinct Apoptotic Pathways in BMECs Induced by Candida krus

  2026-05-18

  Miao et al. (2023) demonstrate that yeast and hypha forms of Candida krusei induce apoptosis in bovine mammary epithelial cells (BMECs) through fundamentally different signaling mechanisms. This distinction advances understanding of fungal mastitis pathogenesis and highlights potential for pathway-specific interventions.

• GS-441524: Mechanisms and Benchmarks in Antiviral Research

  2026-05-17

  GS-441524 is a nucleoside analog prodrug with established antiviral activity and defined conversion pathways. Its solubility, storage, and purity parameters underpin its value in GS-441524 antiviral research, particularly as a SARS-CoV-2 inhibitor. This article synthesizes benchmarked evidence and protocol guidance for reliable scientific deployment.

• Amikacin (BAY416651): Innovations in Targeted Antibiotic Del

  2026-05-16

  Discover how Amikacin (BAY416651) enables breakthroughs in antibiotic resistance research and targeted drug delivery. This article provides a scientific deep dive into its mechanism, resistance factors, and novel granuloma-targeting strategies.

• Difloxacin HCl: Optimizing Quinolone Antimicrobial Antibioti

  2026-05-15

  Difloxacin HCl stands out as a quinolone antimicrobial antibiotic with robust applications in both antimicrobial susceptibility testing and multidrug resistance reversal. This article details protocol enhancements, troubleshooting insights, and advanced workflows to maximize research reproducibility and translational value.

• Grazoprevir Hydrate: Translational Efficacy in Complex HCV C

  2026-05-15

  Discover how Grazoprevir hydrate (MK-5172 hydrate) advances hepatitis C virus replication inhibition for challenging patient populations. This deep dive uniquely analyzes its clinical pharmacology and practical assay parameters for translational and precision antiviral research.

• Zosuquidar (LY335979): Precision P-gp Inhibition in MDR Canc

  2026-05-14

  Zosuquidar (LY335979) 3HCl transforms drug resistance research by enabling precise, selective P-glycoprotein inhibition in both cell and animal models. This guide details applied workflows, data-driven protocol optimization, and troubleshooting for researchers targeting multidrug resistance (MDR) in oncology.

• Direct Mouse Genotyping Kit: Rapid PCR from Mouse Tissue

  2026-05-14

  The Direct Mouse Genotyping Kit enables rapid genomic DNA preparation and PCR amplification directly from mouse tissue without purification. Its PCR master mix with dye supports high-throughput, reliable genotyping for biomedical research applications.

• FITC Goat Anti-Mouse IgG (H+L) Antibody: Technical Guide

  2026-05-13

  The FITC Goat Anti-Mouse IgG (H+L) Antibody addresses the need for reliable, sensitive detection of mouse IgG in immunofluorescence and flow cytometry assays. It is best suited for workflows requiring a fluorescein-conjugated secondary antibody with minimal cross-reactivity and robust signal amplification. This reagent is not recommended for direct antigen detection or applications involving species with high IgG homology to mouse unless cross-reactivity has been evaluated.

• Cisapride (R 51619): Bridging Mechanistic Insight and Cardio

  2026-05-13

  This article empowers translational researchers by blending mechanistic expertise on Cisapride (R 51619) with actionable guidance for cardiac electrophysiology and predictive cardiotoxicity assays. We integrate recent deep learning-enabled iPSC-cardiomyocyte screening breakthroughs, highlight competitive strategies, and provide protocol parameters for robust experimental design. APExBIO's Cisapride is profiled as a high-purity, reproducible reference compound for advancing 5-HT4 signaling and hERG channel inhibition research.

• Nadolol (SQ-11725): Transporter Pharmacokinetics in Vascular

  2026-05-12

  Explore the advanced pharmacokinetic and transporter-focused landscape of Nadolol (SQ-11725) in vascular research. This article uniquely dissects OATP1A2-mediated variability, bridging molecular detail and practical assay design.

• Merbromin as a Selective Mixed-Type Inhibitor of SARS-CoV-2

  2026-05-12

  This study identifies merbromin as a potent, selective mixed-type inhibitor of the SARS-CoV-2 main protease 3CLpro using high-throughput screening. The findings provide mechanistic insights into merbromin’s inhibitory action and offer a molecular scaffold for designing new antiviral agents targeting coronavirus proteases.

16671 records 5/1112 page Previous Next 12345 下5页 Last page